← Back to news
S

Seeking Alpha: News

Dynex Capital Q1 earnings beat, but book value disappoints

B

AI chip startups near record funding to challenge Nvidia, CNBC's Schwarz says

B

VNET Group CFO to step down

B

Tesla adds Dallas and Houston to the robotaxi rollout push

S

Dynex Capital GAAP EPS of -$0.41, net interest income of $79.25M

S

Nektar posts 52-week data from mid-stage trial for hair loss therapy

S

Transoceanic Investments updates OTCQB ticker to 'OCEEF' following name change

S

BNB Plus stock jumps after starting strategic review

S

Marvell gains, Broadcom, Celestica dip on Google report

S

BWX Technologies to buy Precision Components, bolstering nuclear manufacturing

S

China silver imports hit record high on investor, solar demand

B

Eureka Lithium taps capital markets veteran Danny Matthews as new CEO

B

PepsiCo looks to broaden the market for Gatorade beyond sports participants

B

Kustom Entertainment announces 1-for-5 reverse stock split

B

Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research

B

Stablecoins raise regulatory evasion, dollarization risks - BIS head

B

TransAlta appoints Mike Politeski as CFO

S

Broadridge makes minority investment in Centrl, terms undisclosed

S

enCore Energy names Little as new CEO; Sheriff returns as Executive Chair

S

Costco and FedEx face lawsuits as tariff refund portal opens today

S

Ingles Markets sends a letter to shareholders amid its proxy fight

S

Pfizer, Astellas win FDA priority review for Padcev in bladder cancer with Merck’s Keytruda

S

The oil shock that 'dwarfs history' won't have a rapid recovery - SocGen

S

Lululemon launches e-commerce in Mexico as part of its growth plan

S

Cathie Wood's Ark Invest buys proteomics company Alamar, Netflix; trims crypto names

S

Cleveland-Cliffs in charts: Q1 sales volume of steel products rises 9% Q/Q

S

Airline stocks fall again as investors eye capacity cuts, demand pressure, and jet fuel concerns

S

Novo posts late-stage trial win for sickle cell disease therapy

S

Bank of Hawaii GAAP EPS of $1.30 misses by $0.02, revenue of $192.32M misses by $2.07M

S

Tech selloff creates buying opportunity as strong fundamentals hold, Seeking Alpha’s Cress says

S

USA Rare Earth to buy Brazil's Serra Verde in ~$2.8B cash and stock deal

S

Honeywell reportedly close to selling unit to Brady for $1.4B

S

Prelude Therapeutics prices $90M equity offering

S

China’s Netflix iQiyi bets big on AI content in major overhaul

S

Red Rock turns 20: The off-Strip bet that paid off big

B

Earnings Snapshot: Cleveland-Cliffs tops Q1 estimates; reaffirms FY26 outlook

B

AST SpaceMobile stock slides after Blue Origin launch misses planned orbit for satellite

B

Gold, silver pullback overdone as macro tailwinds stay intact, High Yield Investor’s Smith says

B

Ennis GAAP EPS of $0.35, revenue of $96.36M beats by $1.26M

B

Cleveland-Cliffs Non-GAAP EPS of -$0.40 beats by $0.02, revenue of $4.9B beats by $110M

B

AM Markets Need to Know: Berkshire under Abel, Canada-U.S. trade, and more

B

Biggest stock movers Monday: Psychedelic stocks and more

S

IEA chief calls for new Iraq-Turkey oil pipeline to reduce Hormuz reliance - report

S

Bombardier, Vista sign $300M services deal for Challenger 3500 fleet

S

European indexes dip on renewed escalation in tensions with Iran

S

Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains

S

Japan issues tsunami warning after earthquake strikes off coast

S

Faraday Future secures $45M funding

B

Nasdaq, S&P 500, Dow futures fall as hopes of U.S.-Iran peace deal fade

S